Probiotic E. coli (Symbioflor®2) treatment mediates antimicrobial β-defensin (hBD-2) synthesis and fecal excretion in humans
Miriam Schlee(Robert Bosch Hospital), Jan Wehkamp(Robert Bosch Hospital), Klaus Fellermann(Apple (Israel)), Kurt Zimmermann(SymbioPharm (Germany)), EF Stange(Robert Bosch Hospital), H. Huber
Cited by 0
Related Papers
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566